(Q24810584)

English

Relationship of patients' age to histopathological features of breast tumours in BRCA1 and BRCA2 and mutation-negative breast cancer families

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 July 2017

Relationship of patients' age to histopathological features of breast tumours in BRCA1 and BRCA2 and mutation-negative breast cancer families (English)

1 reference

Europe PubMed Central

4 July 2017

1 reference

based on heuristic

inferred from title

Heli Nevanlinna

6

1 reference

Europe PubMed Central

4 July 2017

Kristiina Aittomäki

4

object named as

Kristiina Aittomäki

0 references

5

object named as

Carl Blomqvist

1 reference

Europe PubMed Central

4 July 2017

Päivi Heikkilä

2

object named as

Päivi Heikkilä

1 reference

Europe PubMed Central

4 July 2017

Hannaleena Eerola

1

object named as

Hannaleena Eerola

1 reference

Europe PubMed Central

4 July 2017

Anitta Tamminen

3

object named as

Anitta Tamminen

1 reference

Europe PubMed Central

4 July 2017

language of work or name

0 references

publication date

21 April 2005

1 reference

Europe PubMed Central

4 July 2017

Breast Cancer Research

1 reference

Europe PubMed Central

4 July 2017

7

1 reference

Europe PubMed Central

4 July 2017

R465-9

1 reference

Europe PubMed Central

4 July 2017

4

1 reference

Europe PubMed Central

4 July 2017

Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1175056

7 April 2017

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1175056

7 April 2017

Evidence of founder mutations in Finnish BRCA1 and BRCA2 families

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1175056

7 April 2017

Repeated observation of breast tumor subtypes in independent gene expression data sets

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1175056

7 April 2017

A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1175056

7 April 2017

Tissue microarrays for high-throughput molecular profiling of tumor specimens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1175056

7 April 2017

Comparison of age-specific incidence rate patterns for different histopathologic types of breast carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1175056

28 September 2017

Estrogen receptor status in BRCA1- and BRCA2-related breast cancer: the influence of age, grade, and histological type

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1175056

28 September 2017

A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1175056

28 September 2017

Breast carcinomas arising in carriers of mutations in BRCA1 or BRCA2: are they prognostically different?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1175056

28 September 2017

Using gene carrier probability to select high risk families for identifying germline mutations in breast cancer susceptibility genes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1175056

28 September 2017

Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1175056

28 September 2017

A low proportion of BRCA2 mutations in Finnish breast cancer families.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1175056

28 September 2017

Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1175056

30 May 2018

The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.

1 reference

https://api.crossref.org/works/10.1186%2FBCR1025

21 January 2018

Hormone receptors and proliferation in breast carcinomas of equivalent histologic grades in pre- and postmenopausal women

1 reference

https://api.crossref.org/works/10.1186%2FBCR1025

21 January 2018

BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing.

1 reference

https://api.crossref.org/works/10.1186%2FBCR1025

21 January 2018

RESPONSE: Re: Population-Based Study of BRCA1 and BRCA2 Mutations in 1035 Unselected Finnish Breast Cancer Patients

1 reference

https://api.crossref.org/works/10.1186%2FBCR1025

21 January 2018

Familial breast cancer in southern Finland

1 reference

https://api.crossref.org/works/10.1186%2FBCR1025

21 January 2018

Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes

1 reference

https://api.crossref.org/works/10.1186%2FBCR1025

21 January 2018

Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland

1 reference

https://api.crossref.org/works/10.1186%2FBCR1025

21 January 2018

BRCA1and Medullary Breast Cancer

1 reference

https://api.crossref.org/works/10.1186%2FBCR1025

21 January 2018

Breast tumor immunophenotype of BRCA1-mutation carriers is influenced by age at diagnosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1175056

28 November 2018

A preliminary validation of a family history assessment form to select women at risk for breast or ovarian cancer for referral to a genetics center

1 reference

https://pubmed.ncbi.nlm.nih.gov/15987451

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multiple tissue core arrays in histopathology research: a validation study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15987451

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Re: Population-Based Study of BRCA1 and BRCA2 Mutations in 1035 Unselected Finnish Breast Cancer Patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/15987451

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15987451

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15987451

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinicopathologic analysis of BRCA1- or BRCA2-associated hereditary breast carcinoma in Japanese women

1 reference

https://pubmed.ncbi.nlm.nih.gov/15987451

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Novel indications for BRCA1 screening using individual clinical and morphological features

1 reference

https://pubmed.ncbi.nlm.nih.gov/15987451

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Major improvement in the efficacy of BRCA1 mutation screening using morphoclinical features of breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15987451

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/BCR1025

1 reference

Europe PubMed Central

4 July 2017

Dimensions Publication ID

0 references

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Europe PubMed Central

4 July 2017

ResearchGate publication ID

0 references

Springer Nature article ID

10.1186/bcr1025

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24810584&oldid=1833393707"